
高純度キラル化合物
特徴
- エマルジョンでの結晶化による独自の分割技術により低コスト/高純度を実現
- 数gの臨床研究用から、100mt以上の商業ベースでの供給が可能
- 幅広い製造実績とカスタム製造が可能
Chiral Compounds
D-Alanine [338-69-2]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
D-Alaninol [35320-23-1]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(R)-2-Aminobutane [13250-12-9]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(S)-2-Aminobutane [513-49-5]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(R)-2-Amino-1-butanol [5856-63-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(S)-2-Amino-1-butanol [5856-62-2]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Ethambutol
(R,R)-trans-2-Aminocyclopentanol hydrochloride [68327-11-7]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(S,S)-trans-2-Aminocyclopentanol hydrochloride [68327-04-8]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(1S,4R)-4-Aminocyclopent-2-ene-1- carboxylic acid methylester hydrochloride [229613-83-6]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Abacavir, Peramivir
(R)-3-Aminopiperidine dihydrochloride [334618-23-4]

Chemical purity ≥97%
Enantiomeric ratio ≥99:1
Use: Alogliptin, Linagliptin
(S)-3-Aminopiperidine dihydrochloride [334618-07-4]

Chemical purity ≥97%
Enantiomeric ratio ≥99:1
(R)-1-Amino-2-propanol [2799-16-8]

Chemical purity ≥98%
Enantiomeric ratio ≥99.5:0.5
(S)-1-Amino-2-propanol [2799-17-9]

Chemical purity ≥99%
Enantiomeric ratio ≥99.5:0.5
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy) propyl]-2,3-dihydro-1H-indole-7- carbonitrile L-tartrate [239463-85-5]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Silodosin
(R)-1-Amino-1,2,3,4-tetrahydronaphthalene / (R)-1-Aminotetraline [23357-46-2]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(S)-1-Amino-1,2,3,4-tetrahydronaphthalene / (S)-1-Aminotetraline [23357-52-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
D-Arginine hydrochloride [627-75-8]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use: Etelcalcetide
(1R,4S)-2-Azabicyclo[2.2.1]hept-5-en-3- one / (-)-Vince Lactame [79200-56-9]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Abacavir, Bictegravir
(1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3- one / (+)-Vince Lactame [1309031-83-8]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
rac-1,1’-Bi-2-naphthol [602-09-5]

Chemical purity ≥99%
Use. BINAP
(R)-1,1’-Bi-2-naphthol [18531-94-7]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. R-BINAP
(S)-1,1’-Bi-2-naphthol [18531-99-2]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Esomeprazole,S-BINAP
rac-1,1’-Binaphthalene-2,2’-diyl hydrogenphosphate [35193-63-6]

Chemical purity ≥99%
(R)-1,1’-Binaphthalene-2,2’-diyl hydrogenphosphate [39648-67-4]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(S)-1,1’-Binaphthalene-2,2’-diyl hydrogenphosphate [35193-64-7]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(2R,3R)-2,3-Butanediol [24347-58-8]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(2S,3S)-2,3-Butanediol [19132-06-0]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(R)-3-Butyn-2-ol [42969-65-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Vorapaxar
(S)-3-Butyn-2-ol [2914-69-4]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(R)-2-Chloromandelic acid [52950-18-2]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Clopidogrel
(S)-2-Chloromandelic acid [52950-19-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Carisbamate
cis-1,2-Diaminocyclohexane [1436-59-5]

Chemical purity ≥99%
trans-1,2-Diaminocyclohexane [1121-22-8]

Chemical purity ≥99%
(1R,2R)-1,2-Diaminocyclohexane [20439-47-8]

Chemical purity ≥99%
Enantiomeric ratio ≥99,9:0.1
Use. Oxaliplatin
(1S,2S)-1,2-Diaminocyclohexane [21436-03-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(R)-1,2-Diaminopropane dihydrochloride [19777-67-4]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(S)-1,2-Diaminopropane dihydrochloride [19777-66-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(2S)-3-(Dimethylamino)-1-(3- methoxyphenyl)-2-methyl-1-propanone [850222-40-1]

Chemical purity ≥99%
Enantiomeric ratio ≥98:2
Use: Tapentadol
(5R)-5-(2,2-Dimethyl-4H-1,3- benzodioxin-6-yl)-1,3-oxazolidin-2-one [452339-73-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use: Vilanterol
(R)-2,2-Dimethyl-1,3-dioxolane-4- carboxylic acid methylester [52373-72-5]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(S)-2,2-Dimethyl-1,3-dioxolane-4- carboxylic acid methylester [60456-21-5]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(1R,2R)-1,2-Diphenylethylenediamine / R-DPEN [35132-20-8]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(1S,2S)-1,2-Diphenylethylenediamine / S-DPEN [29841-69-8]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(1R,2R)-N-(4-Toluenesulfonyl)-1,2- Diphenylethylenediamine / R-TsDPEN [144222-34-4]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(1S,2S)-N-(4-Toluenesulfonyl)-1,2- Diphenylethylenediamine / S-TsDPEN [167316-27-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(R)-Ethyl nipecotate [25137-01-3]

Chemical purity ≥97%
Enantiomeric ratio ≥99:1
Use. Tiagabine
(S)-Ethyl nipecotate [37675-18-6]

Chemical purity ≥97%
Enantiomeric ratio ≥99:1
(R)-6-Fluoro-3,4-dihydro-2H-1- benzopyran-2-carboxylic acid / Fluorochromanic acid [129101-37-7]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Nebivolol
(S)-6-Fluoro-3,4-dihydro-2H-1- benzopyran-2-carboxylic acid / Fluorochromanic acid [129101-36-6]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Nebivolol
(R)-1-(2-Fluorophenyl)ethanol (162427-79-4)

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(S)-1-(2-Fluorophenyl)ethanol (171032-87-4)

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(R)-Indoline-2-carboxylic acid [98167-06-7]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(S)-Indoline-2-carboxylic acid [79815-20-6]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use: Perindopril
D-Malic acid [636-61-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Eszopiclone
D-Mandelic acid [611-71-2]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
L-Mandelic acid [17199-29-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
trans-Mentha-2,8-dien-1-ol [22972-51-6]

Chemical purity ≥95%
Enantiomeric ratio ≥99:1
Use: synthetic Cannabidiol
(S)-3-Methylamino-1-(thiophene-2-yl)- propan-1-ol [116539-55-0]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Duloxetine
(R)-2-Methyl-2,4-pentanediol [99210-90-9]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(S)-2-Methyl-2,4-pentanediol[99210-91-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use. Catalyst ligand
(R)-1-(1-Naphthyl)-ethylamine [3886-70-2]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use: Cinacalcet
(S)-1-(1-Naphthyl)-ethylamine [10420-89-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(R)-Nipecotic acid hydrochloride [885949-15-5]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
(S)-Nipecotic acid hydrochloride [851956-01-9]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
D-Phenylalanine [673-06-3]

Assay: 98 - 102%
Enantiomeric ratio ≥99:1
(R)-1-Phenylethylamine [3886-69-9]

Chemical purity ≥99%
Enantiomeric ratio ≥99,9:0,1
(S)-1-Phenylethylamine [2627-86-3]

Chemical purity ≥99%
Enantiomeric ratio ≥99,9:0,1
(2R,3S)-3-Phenylisoserine hydrochloride [132201-32-2]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use. Docetaxel, Paclitaxel
(S)-1-Piperidino-phenyl)-3-methylbutylamine [147769-93-5]

Chemical purity ≥99%
Enantiomeric ratio ≥99,5:0,1
Use: Repaglinide
D-Proline [344-25-2]

Assay: 98 - 102%
Enantiomeric ratio ≥99:1
(R)-2-Tetrahydrofuroic acid [87392-05-0]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
Use: Faropenem
(S)-2-Tetrahydrofuroic acid [87392-07-2]

Chemical purity ≥98%
Enantiomeric ratio ≥99:1
(R)-1,2,3,4-Tetrahydropapaverine hydrochloride [54417-53-7]

Chemical purity ≥99%
Enantiomeric ratio ≥99:1
Use: Cisatracurium
D-Tryptophan hydrochloride [36760-44-8]

Assay: 96 - 102%
Enantiomeric ratio ≥99:1
Use: Tadalafil
Chiral Compounds
Product name | CAS |
D-Alanine | 338-69-2 |
D-Alaninol / (R)-2-Amino-1-propanol | 35320-23-1 |
(R)-2-Aminobutane | 13250-12-9 |
(S)-2-Aminobutane | 513-49-5 |
(R)-2-Aminobutanoic acid | 2623-91-8 |
(S)-2-Aminobutanoic acid | 1492-24-6 |
(R)-2-Amino-1-butanol | 5856-63-3 |
(S)-2-Amino-1-butanol | 5856-62-2 |
(1R,2R)-trans-2-Aminocyclopentanol hydrochloride | 68327-11-7 |
(1S,2S)-trans-2-Aminocyclopentanol hydrochloride | 68327-04-8 |
(1R,3S)-3-Aminocyclopentanol | 1110772-05-8 |
(1R,3S)-3-Aminocyclopentanol hydrochloride | 1279032-31-3 |
(1S,4R)-4-Amino-2-cyclopentene-1-methanol | 136522-35-5 |
(1S,4R)-4-Amino-2-cyclopentene-1-methanol D-tartrate | 229177-52-0 |
(1S,4R)-4-Amino-2-cyclopentene-1-methanol hydrochloride | 168960-19-8 |
(1S,4R)-4-Aminocyclopent-2-ene-1-carboxylic acid methylester hydrochloride | 229613-83-6 |
(1R,2S)-cis-1-Amino-2-indanol | 136030-00-7 |
(1S,2R)-cis-1-Amino-2-indanol | 126456-43-7 |
(R)-1-Aminoindane hydrochloride | 10305-73-4 |
(S)-1-Aminoindane hydrochloride | 32457-23-1 |
(R)-3-Aminopiperidine dihydrochloride | 334618-23-4 |
(S)-3-Aminopiperidine dihydrochloride | 334618-07-4 |
(R)-1-Amino-2-propanol | 2799-16-8 |
(R)-1-Amino-2-propanol hydrochloride | 130680-58-9 |
(S)-1-Amino-2-propanol | 2799-17-9 |
(S)-1-Amino-2-propanol hydrochloride | 84633-04-5 |
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile L-tartrate | 239463-85-5 |
(R)-1-Amino-1,2,3,4-tetrahydronaphthalene / (R)-1-Aminotetraline | 23357-46-2 |
(S)-1-Amino-1,2,3,4-tetrahydronaphthalene / (S)-1-Aminotetraline | 23357-52-0 |
D-Arginine hydrochloride | 627-75-8 |
(1R,4S)-2-Azabicyclo[2.2.1]hept-5-en-3-one / (-)-Vince Lactam | 79200-56-9 |
(1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one / (+)-Vince Lactam | 130931-83-8 |
1,1’-Bi-2-naphthol / rac-BINOL | 602-09-5 |
(R)-1,1’-Bi-2-naphthol / R-BINOL | 18531-94-7 |
(S)-1,1’-Bi-2-naphthol / S-BINOL | 18531-99-2 |
1,1’-Binaphthyl-2,2’-diyl hydrogen phosphate | 35193-63-6 |
(R)-1,1’-Binaphthyl-2,2’-diyl hydrogen phosphate | 39648-67-4 |
(S)-1,1’-Binaphthyl-2,2’-diyl hydrogen phosphate | 35193-64-7 |
(2R,3R)-2,3-Butanediol | 24347-58-8 |
(2R,3S)-2,3-Butanediol | 5341-95-7 |
(2S,3S)-2,3-Butanediol | 19132-06-0 |
(R)-3-Butyn-2-ol | 42969-65-3 |
(S)-3-Butyn-2-ol | 2914-69-4 |
(R)-10-Camphorsulfonic acid | 35963-20-3 |
(S)-10-Camphorsulfonic acid | 3144-16-9 |
(R)-N-(4-Chlorobenzyl hydryl) piperazine | 300543-56-0 |
(R)-2-Chloromandelic acid | 52950-18-2 |
(S)-2-Chloromandelic acid | 52950-19-3 |
(1R,2R)-1,2-Cyclohexane-dimethanol | 65376-05-8 |
(S)-3-Cyclohexene-1-carboxylic acid | 5708-19-0 |
cis-1,2-Diaminocyclohexane | 1436-59-5 |
(1S,2R)-BOC-1,2-Diaminocyclohexane (cis) | 365996-30-1 |
(1R,2R)-1,2-Diaminocyclohexane | 20439-47-8 |
(1R,2R)-1,2-Diaminocyclohexane hydrochloride | 191480-63-4 |
(1R,2R)-1,2-Diaminocyclohexane L-tartrate | 39961-95-0 |
(1S,2S)-1,2-Diaminocyclohexane | 21436-03-3 |
(1S,2S)-1,2-Diaminocyclohexane D-tartrate | 67333-70-4 |
trans-1,2-Diaminocyclohexane (racemic) | 1121-22-8 |
(R)-1,2-Diaminopropane dihydrochloride | 19777-67-4 |
(S)-1,2-Diaminopropane dihydrochloride | 19777-66-3 |
(S)-3-Dimethylamino-1-(3-methoxyphenyl)-2-methyl-1-propanone | 850222-40-1 |
(5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one | 452339-73-0 |
(R)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid methylester | 52373-72-5 |
(S)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid methylester | 60456-21-5 |
(R)-2,2-Dimethyl-1,3-dioxolane-4-carboxaldehyde | 15186-48-8 |
(S)-2,2-Dimethyl-1,3-dioxolane-4-carboxaldehyde | 22323-80-4 |
(R)-2,2-Dimethyl-1,3-dioxolane-4-methanol / (R)-1,2-Isopropylideneglycerol | 14347-78-5 |
(S)-2,2-Dimethyl-1,3-dioxolane-4-methanol / (S)-1,2-Isopropylideneglycerol | 22323-82-6 |
(1R,2R)-1,2-Diphenylethylenediamine / R-DPEN | 35132-20-8 |
(1R,2R)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine / R-DPEN Tos | 144222-34-4 |
(1R,2R)-N-Methanesulfonyl-1,2-diphenylethylenediamine / R-DPEN Mes | 511534-44-4 |
(1R,2R)-N-(2,4,6-Triisopropylbenzenesulfonyl)-1,2-diphenylethylenediamine / R-DPEN Tris |
852212-92-1 |
(1S,2S)-1,2-Diphenylethylenediamine / S-DPEN | 29841-69-8 |
(1S,2S)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine / S-DPEN Tos | 167316-27-0 |
(1S,2S)-N-Methanesulfonyl-1,2-diphenylethylenediamine / S-DPEN Mes | 300345-76-0 |
(1S,2S)-N-(2,4,6-Triisopropylbenzenesulfonyl)-1,2-diphenylethylenediamine / S-DPEN Tris | 247923-41-7 |
(R)-Ethylnipecotate | 25137-01-3 |
(S)-Ethylnipecotate | 37675-18-6 |
(R)-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | 129101-37-7 |
(S)-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | 129101-36-6 |
(R)-1-(2-Fluorphenyl)ethanol | 162427-79-4 |
(S)-1-(2-Fluorphenyl)ethanol | 171032-87-4 |
(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)-ethylamine | 1980023-96-8 |
(R)-Indoline-2-carboxylic acid | 98167-06-7 |
(S)-Indoline-2-carboxylic acid | 79815-20-6 |
D-Malic acid | 636-61-3 |
D-Mandelic acid | 611-71-2 |
L-Mandelic acid | 17199-29-0 |
trans-(+)-Mentha-2,8-dien-1-ol | 22972-51-6 |
(S)-3-Methylamino-1-(thiophene-2-yl)-propan-1-ol | 116539-55-0 |
(R)-2-Methyl-2,4-pentanediol | 99210-90-9 |
(S)-2-Methyl-2,4-pentanediol | 99210-91-0 |
(S)-2-Methylproline | 42856-71-3 |
(R)-1-(1-Naphthyl)ethylamine | 3886-70-2 |
(R)-1-(1-Naphthyl)ethylamine hydrochloride | 82572-04-1 |
(S)-1-(1-Naphthyl)ethylamine | 10420-89-0 |
(S)-1-(1-Naphthyl)ethylamine hydrochloride | 51600-24-9 |
(R)-Nipecotic acid hydrochloride | 885949-15-5 |
(S)-Nipecotic acid hydrochloride | 851956-01-9 |
D-Phenylalanine | 673-06-3 |
D-Phenylalaninol | 5267-64-1 |
(R)-1-Phenylethylamine / R-PEA | 3886-69-9 |
(S)-1-Phenylethylamine / S-PEA | 2627-86-3 |
(2R,3S)-3-Phenylisoserine hydrochloride | 132201-32-2 |
(2R,3S)-3-Phenylisoserine methylester | 131968-74-6 |
(2R,3S)-N-BOC-3-Phenylisoserine methylester | 124605-42-1 |
(S)-1-(2-Piperidino-phenyl)-3-methyl-butylamine | 147769-93-5 |
D-Proline | 344-25-2 |
(R)-3-Quinuclidinol | 25333-42-0 |
(S)-3-Quinuclidinol | 34583-34-1 |
D-threo-Ritalinic acid | 129389-67-9 |
D-threo-Ritalinic acid hydrochloride | 741705-70-4 |
(R)-2-Tetrahydrofuroic acid | 87392-05-0 |
(S)-2-Tetrahydrofuroic acid | 87392-07-2 |
(R)-Tetrahydropapaverine hydrochloride | 54417-53-7 |
D-Tryptophan | 153-94-6 |
D-Tryptophan hydrochloride | 36760-44-8 |
D-Tryptophan methylester hydrochloride | 14907-27-8 |